TCF7L2 is one of the most robustly replicated genetic risk factors for type 2 diabetes (T2D). Carriers of the risk allele (e.g., rs7903146 T) have an approximately 1.4-fold increased odds per allele – statistically significant but far from deterministic. Penetrance is low: most risk allele carriers never develop T2D, and many without the allele still become diabetic. Lifestyle factors such as diet, physical activity, and body weight exert a much larger influence on actual diabetes risk. A DNA test for TCF7L2 can provide a modest risk signal but should not replace clinical risk assessment (fasting glucose, HbA1c, family history). The evidence base is strong (multiple GWAS and meta-analyses), but the effect size is moderate. In summary, TCF7L2 is a risk factor, not destiny. Consumers should interpret this SNP as one small piece of a larger puzzle and avoid making medical decisions based solely on it.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f05aafddd08675925279fa37